非经典β-catenin相互作用促进早期T细胞急性淋巴细胞白血病的白血病起始活性
本研究通过免疫共沉淀联合液相色谱-质谱鉴定T-ALL中β-catenin的功能相关蛋白相互作用,发现β-catenin与FOXO3转录因子非经典相互作用正向调控包括CDK4在内的LIC相关基因;患者来源异种移植和单细胞基因表达数据证实β-catenin/FOXO3依赖基因在CD82+CD117+细胞组分中表达,该组分在MRD及早期T细胞前体ALL中富集LIC。
要点
- β-catenin与FOXO3非经典相互作用正向调控CDK4等LIC相关基因。
- CD82+CD117+细胞组分在MRD及早期T细胞前体ALL中富集LIC。
- β-catenin/FOXO3依赖基因表达见于诊断时及治疗后30天内MRD的白血病细胞。
核心结论
- β-catenin与FOXO3的非经典相互作用正向调控LIC相关基因,包括细胞周期和肿瘤维持的关键调控因子CDK4。
- β-catenin和FOXO3依赖基因在CD82+CD117+细胞组分中表达,该组分在MRD及早期T细胞前体ALL中富集LIC。
- 这些发现提示β-catenin和FOXO3的关键功能作用,并建议根除T-ALL侵袭性细胞亚群的新治疗策略。
研究设计与样本
- 研究采用免疫共沉淀联合液相色谱-质谱鉴定T-ALL中β-catenin的功能相关蛋白相互作用。
- 使用患者来源异种移植中稳定整合的β-catenin和FOXO3活性荧光报告基因验证发现。
- 分析初诊时及标准治疗后30天内MRD的原发患者白血病细胞单细胞水平基因表达数据。
主要发现
- β-catenin与FOXO3转录因子存在非经典功能相互作用,正向调控包括CDK4在内的LIC相关基因。
- 患者来源异种移植中β-catenin和FOXO3活性荧光报告基因识别出LIC活性富集的minor亚群。
- 单细胞基因表达数据显示β-catenin和FOXO3依赖基因表达存在于CD82+CD117+细胞组分,该组分在MRD及早期T细胞前体ALL中显著富集LIC。
临床怎么用
- 原文结论建议根除T-ALL侵袭性细胞亚群的新治疗策略,但未给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T-cell acute lymphoblastic leukemia (T-ALL) is a T-cell malignancy characterized by cell subsets and enriched with leukemia-initiating cells (LICs). β-Catenin modulates LIC activity in T-ALL. However, its role in maintaining established leukemia stem cells remains largely unknown. To identify functionally relevant protein interactions of β-catenin in T-ALL, we performed coimmunoprecipitation followed by liquid chromatography-mass spectrometry. Here, we report that a noncanonical functional interaction of β-catenin with the Forkhead box O3 (FOXO3) transcription factor positively regulates LIC-related genes, including the cyclin-dependent kinase 4, which is a crucial modulator of cell cycle and tumor maintenance. We also confirm the relevance of these findings using stably integrated fluorescent reporters of β-catenin and FOXO3 activity in patient-derived xenografts, which identify minor subpopulations with enriched LIC activity. In addition, gene expression data at the single-cell level of leukemic cells of primary patients at the time of diagnosis and minimal residual disease (MRD) up to 30 days after the standard treatments reveal that the expression of β-catenin- and FOXO3-dependent genes is present in the CD82+CD117+ cell fraction, which is substantially enriched with LICs in MRD as well as in early T-cell precursor ALL. These findings highlight key functional roles for β-catenin and FOXO3 and suggest novel therapeutic strategies to eradicate aggressive cell subsets in T-ALL.
引用
- Panelli P, De Santis E, Colucci M, et al. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia. Blood. 2023. PMID: 36315912. doi:10.1182/blood.2022017079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。